Prestige Consumer Healthcare
PBH
356 hedge funds and large institutions have $3.17B invested in Prestige Consumer Healthcare in 2025 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 126 increasing their positions, 134 reducing their positions, and 59 closing their positions.
6% less repeat investments, than reductions
Existing positions increased: 126 | Existing positions reduced: 134
2.05% less ownership
Funds ownership: 105.31% → 103.26% (-2.1%)
6% less funds holding
Funds holding: 378 → 356 (-22)
24% less capital invested
Capital invested by funds: $4.16B → $3.17B (-$983M)
25% less first-time investments, than exits
New positions opened: 44 | Existing positions closed: 59
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
+$96.9M |
| 2 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
+$32.4M |
| 3 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$20.6M |
| 4 |
WHG
Westwood Holdings Group
Dallas,
Texas
|
+$18.1M |
| 5 |
D.E. Shaw & Co
New York
|
+$17.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$50.9M |
| 2 |
CAM
Congress Asset Management
Boston,
Massachusetts
|
-$49.7M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$35.8M |
| 4 |
Goldman Sachs
New York
|
-$28.9M |
| 5 |
BlackRock
New York
|
-$26M |
PBH Hedge Fund Activity: Q3 2025 in Review
356 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q3 2025, worth a combined $3.17B — down 24% from $4.16B a quarter earlier.
Sellers outnumbered buyers: 59 funds closed out of PBH and 44 opened new positions — a net loss of 15 holders — while 134 trimmed existing stakes and 126 added.
The largest buyer was Ariel Investments, adding an estimated $96.9M. The largest seller was Invesco, cutting an estimated $50.9M.
- 356 institutional investors held Prestige Consumer Healthcare (PBH) as of Q3 2025, down from 378 in Q2 2025.
- Funds reported $3.17B of Prestige Consumer Healthcare stock for Q3 2025, down 24% quarter-over-quarter.
- 44 funds opened new Prestige Consumer Healthcare positions in Q3 2025 and 59 closed out, a net change of -15 holders.
- The largest Prestige Consumer Healthcare buyer in Q3 2025 was Ariel Investments, an estimated $96.9M added.
- The largest Prestige Consumer Healthcare seller in Q3 2025 was Invesco, an estimated $50.9M sold.
Based on aggregated 13F filings for Q3 2025.